This inventor holds 1 USPTO granted patent. Top assignee: Elexopharm Gmbh. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Lorenz Siebenbürger: Innovator in Hormone-Related Disease Treatment
Introduction
Lorenz Siebenbürger is a notable inventor based in Saarbruecken, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for hormone-related diseases. His work focuses on non-steroidal inhibitors that target specific enzymes involved in hormone metabolism.
Latest Patents
Lorenz Siebenbürger holds a patent for "Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2." This patent details the production and use of non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 and type 2 (17β-HSD1 and 17β-HSD2) inhibitors. These inhibitors are particularly relevant for the treatment and prophylaxis of hormone-related diseases.
Career Highlights
Throughout his career, Siebenbürger has demonstrated a commitment to advancing medical science through innovative research. His work has the potential to impact the treatment of various hormone-related conditions, providing new avenues for therapeutic intervention.
Collaborations
He has collaborated with notable colleagues, including Rolf Wolfgang Hartmann and Martin Frotscher, to further enhance the scope and application of his research.
Conclusion
Lorenz Siebenbürger's contributions to the field of biochemistry and his innovative patent for hormone-related disease treatment highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies.